Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Chinese adults with ankylosing spondylitis
NCT01114880Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jan 2010
- Primary completion
- Sep 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in ankylosing spondylitis (AS), sponsored by Abbott Laboratories. Started Jan 2010; status: completed.
02
Drugs
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT01114880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01114880.